Evidence map›Paper›PMID 42321894›Full record

ReviewDiabetology & metabolic syndrome2026

MiRNAs in hyperglycemia-induced metabolic memory: established mechanisms and emerging nuclear activation concepts.

Mei Guo, Huan Duan, Daoping Ru, Shuai Yang, Wenqiang Yu

Abstract readReview
In one paragraph

Review in Diabetology & metabolic syndrome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mei GuoShanghai Xuhui Central Hospital, Fudan University, Shanghai, 200237, China.
Huan DuanShanghai Xuhui Central Hospital, Fudan University, Shanghai, 200237, China.
Daoping RuShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Shuai YangShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China. kuaile5420@sina.com.
Wenqiang YuShanghai Public Health Clinical Center & Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, 200032, China. wenqiangyu@fudan.edu.cn.

Funding

National Nature Science Fundation of China 32270645, 32500465
6 · The paper itself

Abstract

Hyperglycemia-induced metabolic memory refers to the phenomenon in which cells and tissues retain the persistent damage caused by elevated blood glucose even after glucose levels have returned to normal. Studies have demonstrated that noncoding RNAs, particularly microRNAs (miRNAs), contribute to hyperglycemia-induced metabolic memory through the epigenetic regulation of gene expression. Unlike the canonical function of cytoplasmic miRNAs in gene silencing, nuclear-activating miRNAs (NamiRNAs) have been proposed to interact with enhancers and potentially activate gene transcription, representing an emerging mode of nuclear miRNA function that remains to be validated in diabetic systems. In this review, we summarize the current pathogenic mechanisms of hyperglycemia-induced metabolic memory and highlight both the established and emerging roles of miRNAs in epigenetic regulation within this field.

Indexed as

DiabetesEpigenetic regulationHyperglycemia-induced metabolic memoryMicroRNAsNamiRNAsNoncoding RNAs

Identifiers

PMID42321894
PMCPMC13523302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.